Primary Structure of Human Coagulation Factor XIII

  • Akitada Ichinose
  • Earl W. Davie
Part of the Advances in Experimental Medicine and Biology book series (NATO ASI F, volume 231)


Factor XIII (fibrin stabilizing factor or fibrinoligase) is a plasma transglutaminase that plays an important role in the final stages of blood coagulation and the regulation of fibrinolysis. The molecule occurs in blood as a tetramer, a 2 b 2 (about 320 kD), consisting of two a subunits (75 kD each) and two b subunits (80 kD each) as estimated by SDS-polyacrylamide gel electrophoresis (Schwartz et al., 1973; Chung et al., 1974) (Fig. 1). The molecular complex is held together by noncovalent bonds (Schwartz et al., 1973). During the final stage of blood coagulation, thrombin converts the proenzyme (factor XIII) to an active form (factor XIIIa) by releasing an activation peptide (4 kD) from the N-terminus of each of the a subunits (Schwartz et al., 1973; Takagi and Doolittle, 1974). This reaction is stimulated by fibrin monomers (Lewis et al., 1985). In the presence of calcium ions, the activated a dimer dissociates from the b dimer (Cooke and Holbrook, 1974; Chung et al., 1974; Lorand et al., 1974) and binds to fibrin more tightly. Fibrin also lowers the calcium concentration required for the release of the b dimer (Credo et al., 1981). Calcium binds to the a subunit and unmasks its active site (Curtis et al., 1974; Cooke, 1974).


Factor Xiii Blood Coagulation Factor Fibrin Monomer Human Blood Platelet Coagulation Factor Xiii 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., and Dinarello, C. A., 1984, Nucleotide sequence of human monocyte interleukin 1 precursor cDNA, Proc. Natl. Acad. Sci. USA. 81:7907–7911.PubMedCrossRefGoogle Scholar
  2. Bensi, G., Raugei, G., Klefenz, H., and Cortese, R., 1985, Structure and expression of the human haptoglobin locus, EMBO J., 4:119–126.PubMedGoogle Scholar
  3. Board, P. G., 1979, Genetic polymorphism of the a subunit of human coagulation factor XIII, Am. J. Hum. Genet., 31:116–124.PubMedGoogle Scholar
  4. Bohn, H., 1970, Isolierung und Charakterisierung des fibrinstabilisierenden faktors aus menschlichen thrombozyten, Thromb. Diath. Haemorrh., 23:455–468.PubMedGoogle Scholar
  5. Bohn, H., Haupt, H., and Kranz, T., 1972, Die molekulare struktur der fibrinstabilisierenden faktoren des menschen, Blut, 25:235–248.PubMedCrossRefGoogle Scholar
  6. Campbell, R. D., Bentley, D. R., and Morley, B. J., 1984, The factor B and C2 genes, Phil. Trans. R. Soc. Lond., B 306:367–378.CrossRefGoogle Scholar
  7. Carmassi, F., and Chung, S. I., 1983, Regulation of fibrinolysis by factor XIII, Prog. Fibrinolysis, 6:281–285.Google Scholar
  8. Castle, S. L., and Board, P. G., 1985, An extended survey of the genetic polymorphism at the human coagulation factor XIII: A subunit structural locus, Hum. Hered. 35:101–106.PubMedCrossRefGoogle Scholar
  9. Chen, R., and Doolittle, R. F., 1971, Gamma-gamma cross-linking sites in human and bovine fibrin, Biochemistry, 10:4486–4491.CrossRefGoogle Scholar
  10. Chung, S. I., Lewis, M. S., and Folk, J. E., 1974, Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures, J. Biol. Chem., 249:940–950.PubMedGoogle Scholar
  11. Cohen, I., Young-Bandala, L., Blankenberg, T. A., Siefring, G. E., and Bruner-Lorand, J., 1979, Fibrinoligase-catalyzed cross-linking of myosin from platelet and skeletal muscle, Arch. Biochem. Biophys., 192:100–111.PubMedCrossRefGoogle Scholar
  12. Cohen, I., Glaser, T., Veis, A., and Bruner-Lorand, J., 1981, Ca2+-dependent cross-linking processes in human platelets, Biochim. Biophys. Acta, 676:137–147.PubMedCrossRefGoogle Scholar
  13. Connellan, J. M., Chung, S. I., Whetzel, N. K., Bradley, L. M., and Folk, J. E., 1971, Structural properties of guinea pig liver transglutaminase, J. Biol. Chem., 246:1093–1098.PubMedGoogle Scholar
  14. Cooke, R. D., 1974, Calcium-induced dissociation of human plasma factor XIII and the appearance of catalytic activity, Biochem. J., 141:683–691.PubMedGoogle Scholar
  15. Cooke, R. D., and Holbrook, J. J., 1974, The calcium-induced dissociation of human plasma clotting factor XIII, Biochem. J., 141:79–84.PubMedGoogle Scholar
  16. Cottrell, B. A., Strong, D. D., Watt, K. W. K., and Doolittle, R. F., 1979, Amino acid sequence on the alpha chain of human fibrinogen, Biochemistry. 18:5405–5410.PubMedCrossRefGoogle Scholar
  17. Credo, R. B., Curtis, C. G., and Lorand, L., 1981, Alpha-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa), Biochemistry. 20:3770–3778.PubMedCrossRefGoogle Scholar
  18. Curtis, C. G., Brown, K. L., Credo, R. B., Domanik, R. A., Gray, A., Stenberg, P., and Lorand, L., 1974, Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor, Biochemistry, 13:3774–3780.PubMedCrossRefGoogle Scholar
  19. Davie, E. W., Ichinose, A., and Leytus, S. P., 1986, Structural features of the proteins participating in blood coagulation and fibrinolysis, Cold Spring Harbor Symp. Quant. Biol., 51:509–514.PubMedCrossRefGoogle Scholar
  20. Duckert, F., 1972, Documentation of the plasma factor XIII deficiency in man, Ann. N.Y. Acad. Sci., 202:190–199.PubMedCrossRefGoogle Scholar
  21. Emori, Y., Kawasaki, H., Sugihara, H., Imajoh, S., Kawashima, S., and Suzuki, K., 1986, Isolation and sequence analyses of cDNA clones for the large subunits of two isozymes of rabbit calcium-dependent protease, J. Biol. Chem., 261:9465–9471.PubMedGoogle Scholar
  22. Fear, J. D., Jackson, P., Gray, C., Miloszewski, K. J. A., and Losowsky, M. S., 1984, Localization of factor XIII in human tissues using an immunoperioxidase technique, J. Clin. Pathol., 37:560–563.PubMedCrossRefGoogle Scholar
  23. Folk, J. E., and Finlayson, J. S., 1977, The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases, Adv. Prot. Chem., 31:1–133.Google Scholar
  24. Grinnell, F., Feld, M., and Minter, D., 1980, Fibroblast adhesion to fibrinogen and fibrin substrata: Requirement for cold-insoluble globulin (plasma fibronectin), Cell, 19:517–525.PubMedCrossRefGoogle Scholar
  25. Grundmann, U., Amann, E., Zettlmeissl, G., and Kupper, H. A., 1986, Characterization of cDNA coding for human factor XIIIa, Proc. Natl. Acad. Sci. USA. 83:8024–8028.PubMedCrossRefGoogle Scholar
  26. Henriksson, P., Becker, S., Lynch, G., and McDonagh, J., 1985, Identification of intracellular factor XIII in human monocytes and macrophages, J. Clin. Invest., 76:528–534.PubMedCrossRefGoogle Scholar
  27. Holbrook, J. J., Cooke, R. D., and Kingston, I. B., 1973, The amino acid sequence around the reactive cysteine residue in human plasma factor XIII, Biochem. J., 135:901–903.PubMedGoogle Scholar
  28. Ichinose, A., and Aoki, N., 1982, Reversible cross-linking of alpha2-plasmin inhibitor to fibrinogen by fibrin-stabilizing factor, Biochim. Biophys. Acta. 706:158–164.PubMedCrossRefGoogle Scholar
  29. Ichinose, A., Tamaki, T., and Aoki, N., 1983, Factor XIII-mediated crosslinking of NH2-terminal peptide of alpha2-plasmin inhibitor to fibrin, FEBS Lett., 153:369–371.PubMedCrossRefGoogle Scholar
  30. Ichinose, A., Hendrickson, L. E., Fujikawa, K., and Davie, E. W., 1986a, Amino acid sequence of the a subunit of human factor XIII, Biochemistry. 25:6900–6906.PubMedCrossRefGoogle Scholar
  31. Ichinose, A., McMullen, B. A., Fujikawa, K., and Davie, E. W., 1986b, Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments, Biochemistry. 25:4633–4638.PubMedCrossRefGoogle Scholar
  32. Ichinose, A., Bottenus, R. E., Loeb, K. R., and Davie, E. W., 1987, Isolation and characterization of the genes for the a and b subunits of human factor XIII, Thromb. Haemostas., in press.Google Scholar
  33. Kiesselbach, T. H., and Wagner, R. H., 1972, Demonstration of factor XIII in human megakaryocytes by a fluorescent antibody technique, Ann. N.Y. Acad. Sci., 202:318–328.PubMedCrossRefGoogle Scholar
  34. Kimura, S., and Aoki, N., 1986, Cross-linking site in fibrinogen for alpha2-plasmin inhibitor, J. Biol. Chem., 261:15591–15595.PubMedGoogle Scholar
  35. Kurosky, A., Barnett, D. R., Lee, T. H., Touchstone, B., Hay, R. E., Arnott, M. S., Bowman, B. H., and Fitch, W. M., 1980, Covalent structure of human haptoglobin: A serine protease homolog, Proc. Natl. Acad. Sci. USA. 77:3388–3392.PubMedCrossRefGoogle Scholar
  36. Lopaciuk, S., Lovette, K. M., McDonagh, J., Chuang, H. Y. K., McDonagh, R. P., 1976, Subcellular distribution of fibrinogen and factor XIII in human blood platelets, Thromb. Res., 8:453–465.PubMedCrossRefGoogle Scholar
  37. Lewis, S. D., Janus, T. J., Lorand, L., and Shafer, J. A., 1985, Regulation and formation of factor XIIIa by its fibrin substrates, Biochemistry. 24:6772–6777.PubMedCrossRefGoogle Scholar
  38. Leonard, W. J., Depper, J. M., Crabtree, G. R., Rudikoff, S., Pumpbrey, J., Robb, R. J., Kronke, M., Svetlik, P. B., Peffer, N. J., Waldmann, T. A., and Greene, W. C., 1984, Molecular cloning and expression of cDNAs for the human interleukin-2 receptor, Nature, 311:626–631.PubMedCrossRefGoogle Scholar
  39. Leonard, W. J., Depper, J. M., Kanehisa, M., Kronke, M., Peffer, N. J., Svetlik, P. B., Sullivan, M., and Greene, W. C., 1985, Structure of the human interleukin-2 receptor gene, Science, 230:633–639.PubMedCrossRefGoogle Scholar
  40. Leytus, S. P., Kurachi, K., Sakariassen, K. S., and Davie, E. W., 1986, Nucleotide sequence of the cDNA coding for human complement Clr, Biochemistry. 25:4855–4863.PubMedCrossRefGoogle Scholar
  41. Lintin, S. J., and Reid, K. B. M., 1986, Studies on the structure of the human C4b-binding protein, FEBS Lett., 204:77–81.PubMedCrossRefGoogle Scholar
  42. Lorand, L., 1972, Fibrinoligase: The fibrin-stabilizing factor system of blood plasma, Ann. N.Y. Acad. Sci., 202:6–30.PubMedCrossRefGoogle Scholar
  43. Lorand, L., Gray, A. J., Brown, K., Credo, R. B., Curtis, C. G., Domanik, R. A., and Sternberg, P., 1974, Dissociation of the subunit structure of fibrin stabilizing factor during activation of the zymogen, Biochem. Biophys. Res. Commun., 56:914–922.PubMedCrossRefGoogle Scholar
  44. Lorand, L., Losowsky, M. S., and Miloszewski, K. J. M., 1980, Human factor XIII: Fibrin-stabilizing factor, Prog. Hemost. Thromb., 5:245–290.PubMedGoogle Scholar
  45. Lozier, J., Takahashi, N., and Putnam, F. W., 1984, Complete amino acid sequence of human plasma beta2-glycoprotein I, Proc. Natl. Acad. Sci. USA. 81:3640–3644.PubMedCrossRefGoogle Scholar
  46. McDonagh, R. P., McDonagh, J., Petersen, T. E., Thogersen, H. C., Skorstengaard, K., Sottrup-Jensen, L., and Magnusson, S., 1981, Amino acid sequence of the factor XIIIa acceptor site in bovine plasma fibronectin, FEBS Lett., 127:174–178.PubMedCrossRefGoogle Scholar
  47. Medof, M. E., Lublin, D. M., Holers, V. M., Ayers, D. J., Getty, R. R., Leykam, J. F., Atkinson, J. P., and Tykocinski, M. L., 1987, Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement, Proc. Natl. Acad. Sci. USA. 84:2007–2011.PubMedCrossRefGoogle Scholar
  48. Mole, J. E., Anderson, J. K., Davison, E. A., and Woods, D. E., 1984, Complete primary structure of the zymogen of human complement factor B, J. Biol. Chem., 259:3407–3412.PubMedGoogle Scholar
  49. Mosher, D. F., 1975, Cross-linking of cold-insoluble globulin by fibrin- stabilizing factor, J. Biol. Chem., 250:6614–6621.PubMedGoogle Scholar
  50. Mosher, D. F., Schad, P. E., and Kleinman, H. K., 1979, Cross-linking of fibronectin to collagen by blood coagulation factor XIIIa, J. Clin. Invest., 64:781–787.PubMedCrossRefGoogle Scholar
  51. Mui, P. T. K., and Ganguly, P., 1977, Cross-linking of actin and fibrin by fibrin-stabilizing factor, Am. J. Physiol., 233:H346–H349.PubMedGoogle Scholar
  52. Muszbek, L., Adany, R., Szegedi, G., Polgar, J., and Kavai, M., 1985, Factor XIII of blood coagulation in human monocytes, Thromb. Res., 37:401–410.PubMedCrossRefGoogle Scholar
  53. Nikaido, T., Shimizu, A., Ishida, N., Sabe, H., Teshigawara, K., Maeda, M., Uchiyama, T., Yodoi, J., and Honjo, T., 1984, Molecular cloning of cDNA encoding human interleukin-2 receptor, Nature. 311:631–635.PubMedCrossRefGoogle Scholar
  54. Pierschbacher, M. D., and Ruoslahti, E., 1984, Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule, Nature, 309:30–33.PubMedCrossRefGoogle Scholar
  55. Pisano, J. J., Bronzert, T. J., Peyton, M. P., and Finlayson, J. S., 1972, Epsilon-(gamma-glutamyl)lysine cross-link: Determination in fibrin from normal and factor XIII deficient individuals, Ann. N.Y. Acad. Sci., 202:98–113.PubMedCrossRefGoogle Scholar
  56. Sakata, Y., and Aoki, N., 1980, Cross-linking of alpha2-plasmin inhibitor to fibrin by fibrin-stabilizing factor, J. Clin. Invest., 65:290–297.PubMedCrossRefGoogle Scholar
  57. Sakata, Y., and Aoki, N., 1982, Significance of cross-linking of alpha2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasia, J. Clin. Invest., 69:536–542.PubMedCrossRefGoogle Scholar
  58. Schrode, J., Chung, S. I., and Folk, J. E., 1976, Thrombin cleavage products of human placental transglutaminase, Fed. Proc., 35:1487.Google Scholar
  59. Schwartz, M. L., Pizzo, S. V., Hill, R. L., and McKee, P. A., 1973, Human factor XIII from plasma and platelets, J. Biol. Chem., 248:1395–1407.PubMedGoogle Scholar
  60. Shen, L. L., Hermans, J., McDonagh, J., McDonagh, R. P., and Carr, M., 1975, Effects of calcium ion and covalent crosslinking on formation and elasticity of fibrin gels, Thromb. Res., 6:255–265.PubMedCrossRefGoogle Scholar
  61. Shen, L., and Lorand, L., 1983, Contribution of fibrin stabilization to clot strength, J. Clin. Invest., 71:1336–1341.PubMedCrossRefGoogle Scholar
  62. Sixma, J. J., van den Berg, A., Schiphorst, M., Gueze, H. J., McDonagh, J., 1984, Immunocytochemical localization of albumin and factor XIII in thin cryo sections of human blood platelets, Thromb. Haemostas., 51:388–391.Google Scholar
  63. Takagi, T., and Doolittle, R. F., 1974, Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin, Biochemistry, 13:750–756.PubMedCrossRefGoogle Scholar
  64. Takahashi, N., Takahashi, Y., and Putnam, F. W., 1986, Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta, Proc. Natl. Acad. Sci. USA. 83:8019–8023.PubMedCrossRefGoogle Scholar
  65. Tamaki, T., and Aoki, N., 1981, Cross-linking of alpha2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor, Biochim. Biophvs. Acta, 661:280–286.CrossRefGoogle Scholar
  66. Tamaki, T., and Aoki, N., 1982, Cross-linking of alpha2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor, J. Biol. Chem., 257:14767–14772.PubMedGoogle Scholar
  67. Tufty, R. M., and Kretsinger, R. H., 1975, Troponin and parvalbumin calcium binding regions predicted in myosin light chain and T4 lysozyme, Science, 187:167–169.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Akitada Ichinose
    • 1
  • Earl W. Davie
    • 1
  1. 1.Department of BiochemistryUniversity of WashingtonSeattleUSA

Personalised recommendations